Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
2.870
+0.070 (2.50%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Akoya Biosciences Market Cap
Akoya Biosciences has a market cap or net worth of $142.06 million as of October 24, 2024. Its market cap has decreased by -27.78% in one year.
Market Cap
142.06M
Enterprise Value
174.58M
1-Year Change
-27.78%
Ranking
Category
Stock Price
$2.87
Market Cap Chart
Since the IPO on April 16, 2021, Akoya Biosciences's market cap has decreased from $713.79M to $142.06M, a decrease of -80.10%. That is a compound annual growth rate of -36.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 138.60M | -42.13% |
| Dec 29, 2023 | 239.50M | -34.06% |
| Dec 30, 2022 | 363.20M | -36.25% |
| Dec 31, 2021 | 569.70M | -20.19% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cardiol Therapeutics | 146.48M |
| Vigil Neuroscience | 145.90M |
| Tenaya Therapeutics | 144.36M |
| Eledon Pharmaceuticals | 143.85M |
| Skye Bioscience | 143.80M |
| Akso Health Group | 141.53M |
| Repare Therapeutics | 140.28M |
| Puma Biotechnology | 139.54M |